Neighbors D. Pharmacoeconomic endpoints in FUMA3007: a randomized, open-label study comparing a 28-day oral regimen of 5-fluorouracil plus 776c85 to intravenous gemcitabine for the first-line treatment of patients with unresectable advanced adenocarcinoma of the pancreas. Presented at the Investigator Meeting; 1997. Atlanta, GA.
Neighbors D. Development and use of interactive drug value models. Presented at the UNC School of Pharmacy; 1994. Chapel Hill, NC.
Neighbors D, Mauskopf JA. Importance of quality of life and cost-effectiveness studies in new drug development. Presented at the Southeast Regional Meeting of the American Association of Pharmaceutical Scientists; 1994. Research Triangle Park, NC.